|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07H 19/23 | |
| C07H 13/12 | |||
| C07H 7/033 | |||
| A61K 31/706 | |||
| A61P 25/34 |
| (11) | Number of the document | 1451202 |
| (13) | Kind of document | T |
| (96) | European patent application number | 02803886.7 |
| Date of filing the European patent application | 2002-11-18 | |
| (97) | Date of publication of the European application | 2004-09-01 |
| (45) | Date of publication and mention of the grant of the patent | 2008-08-20 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2002/004820 |
| Date | 2002-11-18 |
| (87) | Number | WO 2003/045967 |
| Date | 2003-06-05 |
| (30) | Number | Date | Country code |
| 334502 P | 2001-11-30 | US |
| (72) |
OBACH, Ronald, S., Pfizer Global Research and Dev., US
HAGEN, Anne, E., Pfizer Global Research and Dev., US
|
| (73) |
Pfizer Products Inc.,
Eastern Point Road, Groton, CT 06340,
US
|
| (54) | ARYL FUSED AZAPOLYCYCLIC COMPOUNDS |
| ARYL FUSED AZAPOLYCYCLIC COMPOUNDS |